Perspective Therapeutics (CATX) Accounts Payables (2011 - 2026)
Perspective Therapeutics recorded quarterly Accounts Payables of $26.5 million in Q1 2026, up 29.13% quarter-over-quarter from $20.5 million in Q4 2025, and up 203.24% year-over-year from $8.7 million in Q1 2025.
Perspective Therapeutics' Accounts Payables history runs 16 years deep, the most recent figure standing at $26.5 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 203.24% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $26.5 million (up 203.24% YoY), while the FY2025 annual figure was $20.5 million, up 98.31% from the prior year.
- Accounts Payables came in at $26.5 million for Q1 2026 at Perspective Therapeutics, up from $20.5 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $26.5 million in Q1 2026 to a low of $150000.0 in Q2 2022.
- A 5-year average of $7.9 million and a median of $6.1 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables sank 73.83% in 2022 and jumped 6913.83% in 2024, its largest moves.
- Perspective Therapeutics' Accounts Payables stood at $233000.0 in 2022, then surged by 2865.24% to $6.9 million in 2023, then jumped by 49.7% to $10.3 million in 2024, then soared by 98.31% to $20.5 million in 2025, then gained by 29.13% to $26.5 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $26.5 million, $20.5 million, and $13.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.57 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.33 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 338.80 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 26.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.49 Mn |
| Dec 31, 2025 | 20.51 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 7.05 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 10.34 Mn |
| Sep 30, 2024 | 21.81 Mn |
| Jun 30, 2024 | 6.13 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 6.91 Mn |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 4.91 Mn |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Sep 30, 2022 | 201,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 769,000.00 |
| Dec 31, 2021 | 847,000.00 |
| Sep 30, 2021 | 768,000.00 |
| Jun 30, 2021 | 98,000.00 |
| Mar 31, 2021 | 992,000.00 |
| Dec 31, 2020 | 66,000.00 |
| Sep 30, 2020 | 758,000.00 |
| Jun 30, 2020 | 654,000.00 |
| Mar 31, 2020 | 45,000.00 |
| Dec 31, 2019 | 632,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Jun 30, 2019 | 133,000.00 |
| Mar 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 113,000.00 |
| Sep 30, 2018 | 1.17 Mn |
| Jun 30, 2018 | 1.39 Mn |
| Mar 31, 2018 | 77,000.00 |
| Dec 31, 2017 | 43,000.00 |
| Sep 30, 2017 | 811,000.00 |
| Jun 30, 2017 | 630,000.00 |
| Mar 31, 2017 | 84,000.00 |
| Dec 31, 2016 | 312,000.00 |
| Sep 30, 2016 | 150,000.00 |
| Jun 30, 2016 | 612,000.00 |
| Mar 31, 2016 | 97,679.00 |
| Dec 31, 2015 | 78,703.00 |
| Jun 30, 2015 | 124,131.00 |
| Jun 30, 2014 | 574,855.00 |
| Mar 31, 2014 | 609,761.00 |
| Dec 31, 2013 | 430,293.00 |
| Sep 30, 2013 | 653,390.00 |
| Jun 30, 2013 | 432,566.00 |
| Mar 31, 2013 | 367,580.00 |
| Dec 31, 2012 | 393,225.00 |
| Sep 30, 2012 | 347,606.00 |
| Jun 30, 2012 | 389,105.00 |
| Mar 31, 2012 | 345,818.00 |
| Dec 31, 2011 | 354,882.00 |
| Sep 30, 2011 | 548,804.00 |
| Jun 30, 2011 | 372,259.00 |